Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

This study has been completed.
Baxter BioScience
National Institutes of Health (NIH)
Information provided by:
Weill Medical College of Cornell University Identifier:
First received: March 3, 2006
Last updated: November 8, 2010
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)